🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
18,54 USD
Máx. histórico
178,74
2142 días
Split 1:6 del 12/07/2012
Caída desde máximo
-89,63%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,20%
Cierre anterior
18,32
Rango de hoy
18,29 – 18,81
Volumen hoy
1.397.929
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,44%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 21 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/08/2023 | 108,02 | 111,77 | 107,54 | 108,02 | +1,91% | 3,92% | 1.887.100 |
| 10/08/2023 | 104,14 | 106,84 | 103,99 | 106,00 | +2,55% | 2,74% | 1.283.600 |
| 09/08/2023 | 103,74 | 104,33 | 102,51 | 103,36 | +0,25% | 1,75% | 694.700 |
| 08/08/2023 | 102,95 | 103,87 | 100,73 | 103,10 | +0,59% | 3,05% | 940.700 |
| 07/08/2023 | 105,00 | 105,50 | 101,60 | 102,50 | -2,67% | 3,71% | 1.026.000 |
| 04/08/2023 | 106,80 | 107,12 | 105,14 | 105,31 | -1,90% | 1,85% | 757.400 |
| 03/08/2023 | 108,04 | 114,14 | 106,20 | 107,35 | +2,05% | 7,35% | 1.384.600 |
| 02/08/2023 | 106,79 | 107,10 | 104,85 | 105,19 | -2,18% | 2,11% | 1.001.500 |
| 01/08/2023 | 108,00 | 108,03 | 105,50 | 107,53 | -0,79% | 2,34% | 866.900 |
| 31/07/2023 | 108,61 | 109,49 | 108,04 | 108,39 | -0,13% | 1,34% | 806.500 |
| 28/07/2023 | 106,47 | 109,48 | 105,61 | 108,53 | +2,85% | 3,63% | 965.300 |
| 27/07/2023 | 105,07 | 105,64 | 102,53 | 105,52 | +1,33% | 2,96% | 1.373.500 |
| 26/07/2023 | 103,74 | 105,48 | 102,69 | 104,13 | -0,12% | 2,69% | 665.800 |
| 25/07/2023 | 104,56 | 105,40 | 103,94 | 104,26 | -0,22% | 1,40% | 609.000 |
| 24/07/2023 | 105,81 | 106,38 | 103,05 | 104,49 | -1,30% | 3,15% | 1.285.300 |
| 21/07/2023 | 105,59 | 107,31 | 105,39 | 105,87 | +1,01% | 1,82% | 1.078.300 |
| 20/07/2023 | 106,00 | 106,44 | 104,50 | 104,81 | -1,04% | 1,83% | 1.194.700 |
| 19/07/2023 | 107,19 | 107,69 | 105,65 | 105,91 | -0,67% | 1,90% | 1.403.400 |
| 18/07/2023 | 107,25 | 108,14 | 106,54 | 106,62 | -0,62% | 1,49% | 698.900 |
| 17/07/2023 | 108,12 | 109,91 | 107,10 | 107,29 | -0,51% | 2,60% | 635.300 |
| 14/07/2023 | 108,58 | 109,00 | 106,35 | 107,84 | -0,61% | 2,44% | 626.900 |
| 13/07/2023 | 108,33 | 109,82 | 107,86 | 108,50 | +0,47% | 1,81% | 617.300 |
| 12/07/2023 | 109,07 | 109,74 | 106,89 | 107,99 | -0,47% | 2,61% | 781.000 |
| 11/07/2023 | 109,64 | 109,64 | 107,60 | 108,50 | -0,91% | 1,86% | 945.600 |
| 10/07/2023 | 108,83 | 110,36 | 108,46 | 109,50 | +0,46% | 1,75% | 1.182.400 |
| 07/07/2023 | 110,00 | 111,05 | 108,59 | 109,00 | -0,91% | 2,24% | 842.300 |
| 06/07/2023 | 111,33 | 111,55 | 109,00 | 110,00 | -1,69% | 2,29% | 986.300 |
| 05/07/2023 | 113,57 | 114,20 | 111,08 | 111,89 | -1,41% | 2,75% | 789.300 |
| 03/07/2023 | 114,06 | 114,48 | 111,67 | 113,49 | -0,90% | 2,46% | 504.300 |
| 30/06/2023 | 112,64 | 116,36 | 110,20 | 114,52 | +2,03% | 5,47% | 1.668.300 |